{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:48:46Z","timestamp":1762177726543,"version":"3.40.3"},"publisher-location":"Cham","reference-count":132,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031598142"},{"type":"electronic","value":"9783031598159"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_33","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"481-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Murine Models of Familial Cytokine Storm Syndromes"],"prefix":"10.1007","author":[{"given":"Benjamin","family":"Volkmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Aichele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Pachlopnik","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"33_CR1","doi-asserted-by":"publisher","first-page":"D723","DOI":"10.1093\/nar\/gkw1040","volume":"45","author":"JA Blake","year":"2017","unstructured":"Blake JA, et al. Mouse Genome Database (MGD)-2017: Community knowledge resource for the laboratory mouse. Nucleic Acids Res. 2017;45:D723\u20139.","journal-title":"Nucleic Acids Res"},{"key":"33_CR2","doi-asserted-by":"publisher","first-page":"14811","DOI":"10.1038\/ncomms14811","volume":"8","author":"S Abolins","year":"2017","unstructured":"Abolins S, et al. The comparative immunology of wild and laboratory mice, Mus musculus domesticus. Nat Commun. 2017;8:14811.","journal-title":"Nat Commun"},{"key":"33_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00424-009-0770-z","volume":"459","author":"H Castrop","year":"2010","unstructured":"Castrop H. Genetically modified mice-successes and failures of a widely used technology. Pflugers Arch Eur J Physiol. 2010;459:557\u201367.","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1242\/dmm.000901","volume":"4","author":"MJ Justice","year":"2011","unstructured":"Justice MJ, Siracusa LD, Stewart AF. Technical approaches for mouse models of human disease. Dis Model Mech. 2011;4:305\u201310.","journal-title":"Dis Model Mech"},{"key":"33_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1101\/pdb.top069807","volume":"2014","author":"JJ Gierut","year":"2014","unstructured":"Gierut JJ, Jacks TE, Haigis KM. Strategies to achieve conditional gene mutation in mice. Cold Spring Harb Protoc. 2014;2014:339\u201349.","journal-title":"Cold Spring Harb Protoc"},{"key":"33_CR6","doi-asserted-by":"publisher","unstructured":"Perlman RL. Mouse models of human disease: an evolutionary perspective. Evol Med Public Health. 2016;eow014 https:\/\/doi.org\/10.1093\/emph\/eow014.","DOI":"10.1093\/emph\/eow014"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13059-016-1024-y","volume":"17","author":"AG Doran","year":"2016","unstructured":"Doran AG, et al. Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations. Genome Biol. 2016;17:167.","journal-title":"Genome Biol"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","volume":"49","author":"RS Sellers","year":"2012","unstructured":"Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains. Vet Pathol. 2012;49:32\u201343.","journal-title":"Vet Pathol"},{"key":"33_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","volume":"26","author":"E Brisse","year":"2015","unstructured":"Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26:263\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/369031a0","volume":"369","author":"D K\u00e4gi","year":"1994","unstructured":"K\u00e4gi D, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31\u20137.","journal-title":"Nature"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.91.23.10854","volume":"91","author":"CM Walsh","year":"1994","unstructured":"Walsh CM, et al. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA. 1994;91:10854\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8 + T cells and interferon gamma are essential for the disorder. Blood. 2004;104:735\u201343.","journal-title":"Blood"},{"key":"33_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1074-7613(03)00079-7","volume":"18","author":"VP Badovinac","year":"2003","unstructured":"Badovinac VP, Hamilton SE, Harty JT. Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity. 2003;18:463\u201374.","journal-title":"Immunity"},{"key":"33_CR15","doi-asserted-by":"publisher","first-page":"11571","DOI":"10.1073\/pnas.91.24.11571","volume":"91","author":"B Lowin","year":"1994","unstructured":"Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA. 1994;91:11571\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/370650a0","volume":"370","author":"B Lowin","year":"1994","unstructured":"Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 1994;370:650\u20132.","journal-title":"Nature"},{"key":"33_CR17","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.4049\/jimmunol.161.12.7063","volume":"161","author":"J Spielman","year":"1998","unstructured":"Spielman J, Lee RK, Podack ER. Perforin\/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol. 1998;161:7063\u201370.","journal-title":"J Immunol"},{"key":"33_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1084\/jem.186.7.989","volume":"186","author":"D K\u00e4gi","year":"1997","unstructured":"K\u00e4gi D, et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med. 1997;186:989\u201397.","journal-title":"J Exp Med"},{"key":"33_CR19","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/JVI.73.2.1665-1667.1999","volume":"73","author":"A M\u00fcllbacher","year":"1999","unstructured":"M\u00fcllbacher A, Hla RT, Museteanu C, Simon MM. Perforin is essential for control of ectromelia virus but not related poxviruses in mice. J Virol. 1999;73:1665\u20137.","journal-title":"J Virol"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1128\/JVI.74.24.11832-11840.2000","volume":"74","author":"E Chang","year":"2000","unstructured":"Chang E, Galle L, Maggs D, Estes DM, Mitchell WJ. Pathogenesis of Herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice. J Virol. 2000;74:11832\u201340.","journal-title":"J Virol"},{"key":"33_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.immuni.2006.09.010","volume":"25","author":"SLH van Dommelen","year":"2006","unstructured":"van Dommelen SLH, et al. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity. 2006;25:835\u201348.","journal-title":"Immunity"},{"key":"33_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/eji.201141902","volume":"42","author":"NW Schmidt","year":"2012","unstructured":"Schmidt NW, Khanolkar A, Hancox L, Heusel JW, Harty JT. Perforin plays an unexpected role in regulating T-cell contraction during prolonged listeria monocytogenes infection. Eur J Immunol. 2012;42:629\u201340.","journal-title":"Eur J Immunol"},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.4049\/jimmunol.174.7.4198","volume":"174","author":"M Gupta","year":"2005","unstructured":"Gupta M, et al. CD8-mediated protection against Ebola virus infection is perforin dependent. J Immunol. 2005;174:4198\u2013202.","journal-title":"J Immunol"},{"key":"33_CR24","doi-asserted-by":"publisher","first-page":"201616574","DOI":"10.1073\/pnas.1616574113","volume":"113","author":"T Wirtz","year":"2016","unstructured":"Wirtz T, et al. Mouse model for acute Epstein-Barr virus infection. Proc Natl Acad Sci USA. 2016;113:201616574.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"290","key":"33_CR25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","volume":"1979","author":"VP Badovinac","year":"2000","unstructured":"Badovinac VP. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science. 2000;1979(290):1354\u20137.","journal-title":"Science"},{"key":"33_CR26","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/eji.201142263","volume":"42","author":"NLL Pham","year":"2012","unstructured":"Pham NLL, Badovinac VP, Harty JT. Epitope specificity of memory CD8 + T cells dictates vaccination-induced mortality in LCMV-infected perforin-deficient mice. Eur J Immunol. 2012;42:1488\u201399.","journal-title":"Eur J Immunol"},{"key":"33_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1073\/pnas.0509054103","volume":"103","author":"J Yang","year":"2006","unstructured":"Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc Natl Acad Sci USA. 2006;103:147\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR28","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","volume":"121","author":"CE Terrell","year":"2013","unstructured":"Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121:5184\u201391.","journal-title":"Blood"},{"key":"33_CR29","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1182\/blood-2013-06-508143","volume":"122","author":"CE Terrell","year":"2013","unstructured":"Terrell CE, Jordan MB. Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice. Blood. 2013;122:2618\u201321.","journal-title":"Blood"},{"key":"33_CR30","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1172\/JCI41264","volume":"120","author":"SN Waggoner","year":"2010","unstructured":"Waggoner SN, Taniguchi RT, Mathew PA, Kumar V, Welsh RM. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J Clin Invest. 2010;120:1925\u201338.","journal-title":"J Clin Invest"},{"key":"33_CR31","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1073\/pnas.1118834109","volume":"109","author":"PA Lang","year":"2012","unstructured":"Lang PA, et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci. 2012;109:1210\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"33_CR32","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.4049\/jimmunol.1103474","volume":"189","author":"MQ Ge","year":"2012","unstructured":"Ge MQ, et al. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-\u03b3 and perforin-dependent mechanisms. J Immunol. 2012;189:2099\u2013109.","journal-title":"J Immunol"},{"key":"33_CR33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1182\/blood-2012-02-410803","volume":"120","author":"L Zangi","year":"2012","unstructured":"Zangi L, et al. Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7. Blood. 2012;120:1647\u201357.","journal-title":"Blood"},{"key":"33_CR34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","volume":"125","author":"FE Sepulveda","year":"2015","unstructured":"Sepulveda FE, et al. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood. 2015;125:1427\u201334.","journal-title":"Blood"},{"key":"33_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fimmu.2012.00377","volume":"3","author":"SN Waggoner","year":"2012","unstructured":"Waggoner SN, Kumar V. Evolving role of 2B4\/CD244 in T and NK cell responses during virus infection. Front Immunol. 2012;3:377.","journal-title":"Front Immunol"},{"key":"33_CR36","doi-asserted-by":"publisher","unstructured":"Madera S, et al. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med. 2016;jem.20150712 https:\/\/doi.org\/10.1084\/jem.20150712.","DOI":"10.1084\/jem.20150712"},{"key":"33_CR37","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","volume":"40","author":"J Crouse","year":"2014","unstructured":"Crouse J, et al. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity. 2014;40:961\u201373.","journal-title":"Immunity"},{"key":"33_CR38","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","volume":"40","author":"HC Xu","year":"2014","unstructured":"Xu HC, et al. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity. 2014;40:949\u201360.","journal-title":"Immunity"},{"key":"33_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212:307\u201317.","journal-title":"J Exp Med"},{"key":"33_CR40","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1084\/jem.187.11.1903","volume":"187","author":"D Binder","year":"1998","unstructured":"Binder D, et al. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med. 1998;187:1903\u201320.","journal-title":"J Exp Med"},{"key":"33_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/emmm.200900009","volume":"1","author":"J Pachlopnik-Schmid","year":"2009","unstructured":"Pachlopnik-Schmid J, et al. Neutralization of IFN\u03b3 defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med. 2009;1:112\u201324.","journal-title":"EMBO Mol Med"},{"key":"33_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2015-07-659813","volume":"127","author":"JE Rood","year":"2016","unstructured":"Rood JE, et al. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood. 2016;127:426\u201335.","journal-title":"Blood"},{"key":"33_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jaci.2015.12.1314","volume":"138","author":"S Humblet-Baron","year":"2016","unstructured":"Humblet-Baron S, et al. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2016;138:200\u2013209.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"33_CR44","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, et al. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood. 2016;127:1666\u201375.","journal-title":"Blood"},{"key":"33_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","volume":"128","author":"S Maschalidi","year":"2016","unstructured":"Maschalidi S, Sepulveda FE, Garrigue A, Fischer A, de Saint Basile G. Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood. 2016;128:60\u201371.","journal-title":"Blood"},{"key":"33_CR46","doi-asserted-by":"crossref","unstructured":"Keenan C, Nichols KE, Albeituni S. Use of the JAK inhibitor Ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis. Front Immunol. 2021;12","DOI":"10.3389\/fimmu.2021.614704"},{"key":"33_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/blood.2019000761","volume":"134","author":"S Albeituni","year":"2019","unstructured":"Albeituni S, et al. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Blood. 2019;134:147\u201359.","journal-title":"Blood"},{"key":"33_CR48","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1182\/blood.2020007930","volume":"138","author":"V Chaturvedi","year":"2021","unstructured":"Chaturvedi V, Lakes N, Tran M, Castillo N, Jordan MB. JAK inhibition for murine HLH requires complete blockade of IFN-\u03b3 signaling and is limited by toxicity of JAK2 inhibition. Blood. 2021;138:1034\u20139.","journal-title":"Blood"},{"key":"33_CR49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00335-005-0164-2","volume":"17","author":"K Crozat","year":"2006","unstructured":"Crozat K, et al. Analysis of the MCMV resistome by ENU mutagenesis. Mamm Genome. 2006;17:398\u2013406.","journal-title":"Mamm Genome"},{"key":"33_CR50","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.20062447","volume":"204","author":"K Crozat","year":"2007","unstructured":"Crozat K, et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med. 2007;204:853\u201363.","journal-title":"J Exp Med"},{"key":"33_CR51","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1182\/blood-2011-01-329607","volume":"117","author":"P Krebs","year":"2011","unstructured":"Krebs P, Crozat K, Popkin D, Oldstone MB, Beutler B. Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood. 2011;117:6582\u20138.","journal-title":"Blood"},{"key":"33_CR52","doi-asserted-by":"publisher","first-page":"44603","DOI":"10.1074\/jbc.M112.414029","volume":"287","author":"J Monfregola","year":"2012","unstructured":"Monfregola J, Johnson JL, Meijler MM, Napolitano G, Catz SD. MUNC13-4 protein regulates the oxidative response and is essential for phagosomal maturation and bacterial killing in neutrophils. J Biol Chem. 2012;287:44603\u201318.","journal-title":"J Biol Chem"},{"key":"33_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1091\/mbc.e15-05-0283","volume":"27","author":"J He","year":"2016","unstructured":"He J, et al. Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses. Mol Biol Cell. 2016;27:572\u201387.","journal-title":"Mol Biol Cell"},{"key":"33_CR54","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1074\/jbc.M115.705871","volume":"291","author":"JL Johnson","year":"2016","unstructured":"Johnson JL, et al. Munc13-4 is a Rab11-binding protein that regulates Rab11-positive vesicle trafficking and docking at the plasma membrane. J Biol Chem. 2016;291:3423\u201338.","journal-title":"J Biol Chem"},{"key":"33_CR55","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1042\/BJ20151150","volume":"473","author":"MC Chicka","year":"2016","unstructured":"Chicka MC, et al. Role of Munc13-4 as a Ca2+\u2212dependent tether during platelet secretion. Biochem J. 2016;473:627\u201339.","journal-title":"Biochem J"},{"key":"33_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/eji.201142343","volume":"43","author":"O D\u2019Orlando","year":"2013","unstructured":"D\u2019Orlando O, et al. Syntaxin 11 is required for NK and CD8+ T-cell cytotoxicity and neutrophil degranulation. Eur J Immunol. 2013;43:194\u2013208.","journal-title":"Eur J Immunol"},{"key":"33_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2012-07-440339","volume":"121","author":"FE Sepulveda","year":"2013","unstructured":"Sepulveda FE, et al. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11. Blood. 2013;121:595\u2013603.","journal-title":"Blood"},{"key":"33_CR58","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1182\/blood-2012-07-441139","volume":"121","author":"T Kogl","year":"2013","unstructured":"Kogl T, et al. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood. 2013;121:604\u201313.","journal-title":"Blood"},{"key":"33_CR59","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1078\/0171-9335-00109","volume":"79","author":"R Prekeris","year":"2000","unstructured":"Prekeris R, Klumperman J, Scheller RH. Syntaxin 11 is an atypical SNARE abundant in the immune system. Eur J Cell Biol. 2000;79:771\u201380.","journal-title":"Eur J Cell Biol"},{"key":"33_CR60","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood-2012-05-430603","volume":"120","author":"S Ye","year":"2012","unstructured":"Ye S, et al. Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. Blood. 2012;120:2484\u201392.","journal-title":"Blood"},{"key":"33_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2141.2008.07191.x","volume":"142","author":"S Zhang","year":"2008","unstructured":"Zhang S, et al. Syntaxin-11 is expressed in primary human monocytes\/macrophages and acts as a negative regulator of macrophage engulfment of apoptotic cells and IgG-opsonized target cells. Br J Haematol. 2008;142:469\u201379.","journal-title":"Br J Haematol"},{"key":"33_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1042\/BJ20120057","volume":"446","author":"K Kim","year":"2012","unstructured":"Kim K, et al. Munc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cells. Biochem J. 2012;446:383\u201394.","journal-title":"Biochem J"},{"key":"33_CR63","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","volume":"125","author":"WA Spessott","year":"2015","unstructured":"Spessott WA, et al. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. Blood. 2015;125:1566\u201377.","journal-title":"Blood"},{"key":"33_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-6164-3","volume-title":"The coat colors of mice","author":"WK Silvers","year":"1979","unstructured":"Silvers WK. The coat colors of mice. New York: Springer; 1979. https:\/\/doi.org\/10.1007\/978-1-4612-6164-3."},{"key":"33_CR65","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1073\/pnas.140212797","volume":"97","author":"SM Wilson","year":"2000","unstructured":"Wilson SM, et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci. 2000;97:7933\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"33_CR66","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1083\/jcb.152.4.825","volume":"152","author":"JC Stinchcombe","year":"2001","unstructured":"Stinchcombe JC, et al. Rab27a is required for regulating secretion in cytotoxic T lymphocytes. J Cell Biol. 2001;152:825\u201333.","journal-title":"J Cell Biol"},{"key":"33_CR67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/blood.V100.1.128","volume":"100","author":"EK Novak","year":"2002","unstructured":"Novak EK, et al. The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background. Blood. 2002;100:128\u201335.","journal-title":"Blood"},{"key":"33_CR68","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/eji.200838488","volume":"38","author":"J Pachlopnik Schmid","year":"2008","unstructured":"Pachlopnik Schmid J, et al. A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). Eur J Immunol. 2008;38:3219\u201325.","journal-title":"Eur J Immunol"},{"key":"33_CR69","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1128\/IAI.05043-11","volume":"79","author":"JL Johnson","year":"2011","unstructured":"Johnson JL, Hong H, Monfregola J, Catz SD. Increased survival and reduced neutrophil infiltration of the liver in rab27a- but not munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. Infect Immun. 2011;79:3607\u201318.","journal-title":"Infect Immun"},{"key":"33_CR70","first-page":"235","volume":"73","author":"JM Bennett","year":"1969","unstructured":"Bennett JM, Blume RS, Wolff SM. Characterization and significance of abnormal leukocyte granules in the beige mouse: a possible homologue for Chediak-Higashi Aleutian trait. Transl Res. 1969;73:235\u201343.","journal-title":"Transl Res"},{"key":"33_CR71","first-page":"17","volume":"32","author":"C Oliver","year":"1975","unstructured":"Oliver C, Essner E. Formation of anomalous lysosomes in monocytes, neutrophils, and eosinophils from bone marrow of mice with Ch\u00e9diak-Higashi syndrome. Lab Investig. 1975;32:17\u201327.","journal-title":"Lab Investig"},{"key":"33_CR72","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-3083.1982.tb00653.x","volume":"15","author":"A Orn","year":"1982","unstructured":"Orn A, et al. Pigment mutations in the mouse which also affect lysosomal functions lead to suppressed natural killer cell activity. Scand J Immunol. 1982;15:305\u201310.","journal-title":"Scand J Immunol"},{"key":"33_CR73","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/278451a0","volume":"278","author":"J Roder","year":"1979","unstructured":"Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 1979;278:451\u20133.","journal-title":"Nature"},{"key":"33_CR74","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/284624a0","volume":"284","author":"K K\u00e4rre","year":"1980","unstructured":"K\u00e4rre K, Klein GO, Kiessling R, Klein G, Roder JC. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature. 1980;284:624\u20136.","journal-title":"Nature"},{"key":"33_CR75","doi-asserted-by":"crossref","unstructured":"Barbosa, M. D. F. S. et al. Identification of the homologous beige and Chediak\u2013Higashi syndrome genes. Nature 382, 262\u2013265 (1996).","DOI":"10.1038\/382262a0"},{"key":"33_CR76","first-page":"162","volume":"220","author":"MP McGarry","year":"1999","unstructured":"McGarry MP, Reddington M, Novak EK, Swank RT. Survival and lung pathology of mouse models of Hermansky-Pudlak syndrome and Chediak-Higashi syndrome. Proc Soc Exp Biol Med. 1999;220:162\u20138.","journal-title":"Proc Soc Exp Biol Med"},{"key":"33_CR77","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1182\/blood-2011-05-356113","volume":"118","author":"B Jessen","year":"2011","unstructured":"Jessen B, et al. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood. 2011;118:4620\u20139.","journal-title":"Blood"},{"key":"33_CR78","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.4049\/jimmunol.1101527","volume":"188","author":"P Chatterjee","year":"2012","unstructured":"Chatterjee P, Tiwari RK, Rath S, Bal V, George A. Modulation of antigen presentation and B cell receptor signaling in B cells of beige mice. J Immunol. 2012;188:2695\u2013702.","journal-title":"J Immunol"},{"key":"33_CR79","first-page":"jem.20141461","volume":"214","author":"A Westphal","year":"2016","unstructured":"Westphal A, et al. Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor\u2013mediated inflammatory responses. J Exp Med. 2016;214:jem.20141461.","journal-title":"J Exp Med"},{"key":"33_CR80","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1126\/science.6600521","volume":"219","author":"GW Balkema","year":"1983","unstructured":"Balkema GW, Mangini NJ, Pinto LH. Discrete visual defects in pearl mutant mice. Science. 1983;219:1085\u20137.","journal-title":"Science"},{"key":"33_CR81","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood.V63.3.536.536","volume":"63","author":"EK Novak","year":"1984","unstructured":"Novak EK, Hui SW, Swank RT. Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. Blood. 1984;63:536\u201344.","journal-title":"Blood"},{"key":"33_CR82","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1182\/blood.V94.1.146.413k39_146_155","volume":"94","author":"L Zhen","year":"1999","unstructured":"Zhen L, et al. Abnormal expression and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to platelet storage pool deficiency in the pearl mouse. Blood. 1999;94:146\u201355.","journal-title":"Blood"},{"key":"33_CR83","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/hmg\/8.2.323","volume":"8","author":"L Feng","year":"1999","unstructured":"Feng L, et al. The \u03b23A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet. 1999;8:323\u201330.","journal-title":"Hum Mol Genet"},{"key":"33_CR84","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1006\/geno.2000.6350","volume":"69","author":"L Feng","year":"2000","unstructured":"Feng L, Rigatti BW, Novak EK, Gorin MB, Swank RT. Genomic structure of the mouse Ap3b1 gene in normal and pearl mice. Genomics. 2000;69:370\u20139.","journal-title":"Genomics"},{"issue":"Pt 2","key":"33_CR85","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1242\/jcs.113.22.4077","volume":"113","author":"W Yang","year":"2000","unstructured":"Yang W, Li C, Ward DM, Kaplan J, Mansour SL. Defective organellar membrane protein trafficking in Ap3b1-deficient cells. J Cell Sci. 2000;113(Pt 2):4077\u201386.","journal-title":"J Cell Sci"},{"issue":"Suppl 8","key":"33_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1034\/j.1600-0749.13.s8.12.x","volume":"13","author":"RT Swank","year":"2000","unstructured":"Swank RT, et al. Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pigment Cell Res. 2000;13(Suppl 8):59\u201367.","journal-title":"Pigment Cell Res"},{"key":"33_CR87","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.4049\/jimmunol.171.8.4149","volume":"171","author":"M Cernadas","year":"2003","unstructured":"Cernadas M, et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J Immunol. 2003;171:4149\u201355.","journal-title":"J Immunol"},{"key":"33_CR88","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.4049\/jimmunol.176.7.4361","volume":"176","author":"LR Young","year":"2006","unstructured":"Young LR, Borchers MT, Allen HL, Gibbons RS, McCormack FX. Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome. J Immunol. 2006;176:4361\u20138.","journal-title":"J Immunol"},{"key":"33_CR89","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1182\/blood-2014-07-586727","volume":"125","author":"R Meng","year":"2015","unstructured":"Meng R, et al. Defective release of \u03b1 granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models. Blood. 2015;125:1623\u201332.","journal-title":"Blood"},{"key":"33_CR90","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1182\/blood-2012-10-463166","volume":"121","author":"B Jessen","year":"2013","unstructured":"Jessen B, et al. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Blood. 2013;121:2943\u201351.","journal-title":"Blood"},{"key":"33_CR91","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1073\/pnas.131193098","volume":"98","author":"MJ Czar","year":"2001","unstructured":"Czar MJ, et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP. Proc Natl Acad Sci. 2001;98:7449\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"33_CR92","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/87713","volume":"2","author":"C Wu","year":"2001","unstructured":"Wu C, et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol. 2001;2:410\u20134.","journal-title":"Nat Immunol"},{"key":"33_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature01318","volume":"421","author":"S Crotty","year":"2003","unstructured":"Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature. 2003;421:282\u20137.","journal-title":"Nature"},{"key":"33_CR94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ncb920","volume":"5","author":"B Chan","year":"2003","unstructured":"Chan B, et al. SAP couples Fyn to SLAM immune receptors. Nat Cell Biol. 2003;5:155\u201360.","journal-title":"Nat Cell Biol"},{"key":"33_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ncb919","volume":"5","author":"S Latour","year":"2003","unstructured":"Latour S, et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat Cell Biol. 2003;5:149\u201354.","journal-title":"Nat Cell Biol"},{"key":"33_CR96","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature07345","volume":"455","author":"H Qi","year":"2008","unstructured":"Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature. 2008;455:764\u20139.","journal-title":"Nature"},{"key":"33_CR97","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1073\/pnas.0710698105","volume":"105","author":"A Veillette","year":"2008","unstructured":"Veillette A, et al. SAP expression in T cells, not in B cells, is required for humoral immunity. Proc Natl Acad Sci USA. 2008;105:1273\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR98","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nm1189","volume":"11","author":"KE Nichols","year":"2005","unstructured":"Nichols KE, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med. 2005;11:340\u20135.","journal-title":"Nat Med"},{"key":"33_CR99","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.20042432","volume":"201","author":"B Pasquier","year":"2005","unstructured":"Pasquier B, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201:695\u2013701.","journal-title":"J Exp Med"},{"key":"33_CR100","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1182\/blood-2012-11-468868","volume":"121","author":"R Das","year":"2013","unstructured":"Das R, et al. The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation. Blood. 2013;121:3386\u201395.","journal-title":"Blood"},{"key":"33_CR101","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jmv.10504","volume":"71","author":"L Yin","year":"2003","unstructured":"Yin L, et al. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia. J Med Virol. 2003;71:446\u201355.","journal-title":"J Med Virol"},{"key":"33_CR102","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/blood-2006-04-018929","volume":"108","author":"S Crotty","year":"2006","unstructured":"Crotty S, McCausland MM, Aubert RD, Wherry EJ, Ahmed R. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood. 2006;108:3085\u201393.","journal-title":"Blood"},{"key":"33_CR103","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.immuni.2012.03.023","volume":"36","author":"Z Dong","year":"2012","unstructured":"Dong Z, et al. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity. 2012;36:974\u201385.","journal-title":"Immunity"},{"key":"33_CR104","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1182\/blood-2012-07-445858","volume":"121","author":"C Rivat","year":"2013","unstructured":"Rivat C, et al. SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease. Blood. 2013;121:1073\u20136.","journal-title":"Blood"},{"key":"33_CR105","doi-asserted-by":"publisher","first-page":"321ra7","DOI":"10.1126\/scitranslmed.aad1565","volume":"8","author":"E Ruffo","year":"2016","unstructured":"Ruffo E, et al. Inhibition of diacylglycerol kinase \u03b1 restores restimulation-induced cell death and reduces immunopathology in XLP-1. Sci Transl Med. 2016;8:321ra7.","journal-title":"Sci Transl Med"},{"key":"33_CR106","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1128\/MCB.21.10.3604-3608.2001","volume":"21","author":"H Harlin","year":"2001","unstructured":"Harlin H, et al. Characterization of XIAP-deficient mice. Mol Cell Biol. 2001;21:3604\u20138.","journal-title":"Mol Cell Biol"},{"key":"33_CR107","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.cdd.4401524","volume":"12","author":"MA Olayioye","year":"2005","unstructured":"Olayioye MA, et al. XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. Cell Death Differ. 2005;12:87\u201390.","journal-title":"Cell Death Differ"},{"key":"33_CR108","doi-asserted-by":"crossref","unstructured":"Bauler LD, Duckett CS, O\u2019Riordan MXD. XIAP regulates cytosol-specific innate immunity to listeria infection. PLoS Pathog. 2008;4","DOI":"10.1371\/journal.ppat.1000142"},{"key":"33_CR109","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BJ20081188","volume":"415","author":"JM Rumble","year":"2008","unstructured":"Rumble JM, et al. Apoptotic sensitivity of murine IAP-deficient cells. Biochem J. 2008;415:21\u20135.","journal-title":"Biochem J"},{"key":"33_CR110","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1101\/gad.1663108","volume":"22","author":"AJ Schile","year":"2008","unstructured":"Schile AJ, Garc\u00eda-Fern\u00e1ndez M, Steller H. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 2008;22:2256\u201366.","journal-title":"Genes Dev"},{"key":"33_CR111","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08229","volume":"460","author":"PJ Jost","year":"2009","unstructured":"Jost PJ, et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature. 2009;460:1035\u20139.","journal-title":"Nature"},{"key":"33_CR112","doi-asserted-by":"publisher","first-page":"20291","DOI":"10.1074\/jbc.M109.096297","volume":"285","author":"H Prakash","year":"2010","unstructured":"Prakash H, Albrecht M, Becker D, Kuhlmann T, Rudel T. Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice. J Biol Chem. 2010;285:20291\u2013302.","journal-title":"J Biol Chem"},{"key":"33_CR113","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1233029","volume":"341","author":"Y Fuchs","year":"2013","unstructured":"Fuchs Y, et al. Sept4\/ARTS regulates stem cell apoptosis and skin regeneration. Science. 2013;341:286\u20139.","journal-title":"Science"},{"key":"33_CR114","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.celrep.2013.07.015","volume":"4","author":"N Unsain","year":"2013","unstructured":"Unsain N, Higgins JM, Parker KN, Johnstone AD, Barker PA. XIAP regulates caspase activity in degenerating axons. Cell Rep. 2013;4:751\u201363.","journal-title":"Cell Rep"},{"key":"33_CR115","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","volume":"7","author":"M Yabal","year":"2014","unstructured":"Yabal M, et al. XIAP restricts TNF- and RIP3-dependent cell death and Inflammasome activation. Cell Rep. 2014;7:1796\u2013808.","journal-title":"Cell Rep"},{"key":"33_CR116","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.15252\/embj.201387244","volume":"33","author":"M Andree","year":"2014","unstructured":"Andree M, et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J. 2014;33:2171\u201387.","journal-title":"EMBO J"},{"key":"33_CR117","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2014-03-564609","volume":"124","author":"W-C Hsieh","year":"2014","unstructured":"Hsieh W-C, et al. Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap\u2212\/\u2212 mice. Blood. 2014;124:2847\u201357.","journal-title":"Blood"},{"key":"33_CR118","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2013-01-479543","volume":"123","author":"IE Gentle","year":"2013","unstructured":"Gentle IE, et al. Inhibitor of apoptosis proteins (IAPs) are required for effective T cell expansion\/survival during anti-viral immunity in mice. Blood. 2013;123:659\u201369.","journal-title":"Blood"},{"key":"33_CR119","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1073\/pnas.1502390112","volume":"112","author":"G Ebert","year":"2015","unstructured":"Ebert G, et al. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci USA. 2015;112:5797\u2013802.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.201600384R","volume":"30","author":"J Gibon","year":"2016","unstructured":"Gibon J, et al. The X-linked inhibitor of apoptosis regulates long-term depression and learning rate. FASEB J. 2016;30:1\u20138.","journal-title":"FASEB J"},{"key":"33_CR121","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1073\/pnas.96.3.1019","volume":"96","author":"J Gonz\u00e1lez-Cabrero","year":"1999","unstructured":"Gonz\u00e1lez-Cabrero J, et al. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci USA. 1999;96:1019\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR122","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.jaci.2019.07.038","volume":"144","author":"B Volkmer","year":"2019","unstructured":"Volkmer B, et al. Recurrent inflammatory disease caused by a heterozygous mutation in CD48. J Allergy Clin Immunol. 2019;144:1441\u20131445.e17.","journal-title":"J Allergy Clin Immunol"},{"key":"33_CR123","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2011-06-363994","volume":"119","author":"M Chen","year":"2012","unstructured":"Chen M, Felix K, Wang J. Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood. 2012;119:127\u201336.","journal-title":"Blood"},{"key":"33_CR124","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood.2019003846","volume":"136","author":"P Tsoukas","year":"2020","unstructured":"Tsoukas P, et al. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation. Blood. 2020;136:2162\u201374.","journal-title":"Blood"},{"key":"33_CR125","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.4049\/jimmunol.163.11.6114","volume":"163","author":"A Nansen","year":"1999","unstructured":"Nansen A, et al. Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. J Immunol. 1999;163:6114\u201322.","journal-title":"J Immunol"},{"key":"33_CR126","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1182\/blood-2010-12-324533","volume":"118","author":"JE Lykens","year":"2011","unstructured":"Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB. Perforin is a critical physiologic regulator of T-cell activation. Blood. 2011;118:618\u201326.","journal-title":"Blood"},{"key":"33_CR127","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1182\/blood-2015-12-688960","volume":"127","author":"FE Sepulveda","year":"2016","unstructured":"Sepulveda FE, et al. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice. Blood. 2016;127:2113\u201321.","journal-title":"Blood"},{"key":"33_CR128","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2013.00448","volume":"4","author":"B Jessen","year":"2013","unstructured":"Jessen B, et al. Graded defects in cytotoxicity determine severity of Hemophagocytic Lymphohistiocytosis in humans and mice. Front Immunol. 2013;4:34\u20136.","journal-title":"Front Immunol"},{"key":"33_CR129","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/febs.12081","volume":"280","author":"RK Singh","year":"2013","unstructured":"Singh RK, et al. Distinct and opposing roles for Rab27a\/Mlph\/MyoVa and Rab27b\/Munc13-4 in mast cell secretion. FEBS J. 2013;280:892\u2013903.","journal-title":"FEBS J"},{"key":"33_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00239","volume":"3","author":"L Chiossone","year":"2012","unstructured":"Chiossone L, et al. Protection from inflammatory organ damage in a murine model of Hemophagocytic Lymphohistiocytosis using treatment with IL-18 binding protein. Front Immunol. 2012;3:1\u201310.","journal-title":"Front Immunol"},{"key":"33_CR131","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4049\/jimmunol.1302282","volume":"192","author":"TS Johnson","year":"2014","unstructured":"Johnson TS, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192:84\u201391.","journal-title":"J Immunol"},{"key":"33_CR132","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1566523214666140918112113","volume":"14","author":"C Booth","year":"2014","unstructured":"Booth C, Carmo M, Gaspar HB. Gene therapy for haemophagocytic lymphohistiocytosis. Curr Gene Ther. 2014;14:437\u201346.","journal-title":"Curr Gene Ther"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:07:37Z","timestamp":1723154857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":132,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_33","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}